Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
Frequently asked questions
What sector does Cann Group Limited (CNGGF) operate in?
Cann Group Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Cann Group Limited (CNGGF) current stock price?
As of the latest data, Cann Group Limited stock price is $0.00, with a previous close of $0.00.
What is Cann Group Limited (CNGGF) current market capitalization?
Cann Group Limited market cap is approximately 4.92 million.
What is Cann Group Limited (CNGGF) Earnings Per Share (EPS)?
The trailing EPS is $0.01.
What is Cann Group Limited (CNGGF) Price-to-Earnings (P/E) ratio?
Cann Group Limited current P/E ratio is 0.3.
What is Cann Group Limited (CNGGF) EBITDA?
Cann Group Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.92 million.
Does Cann Group Limited (CNGGF) pay dividends?
No. Cann Group Limited does not pay a dividend.
What is Cann Group Limited (CNGGF) beta (volatility) score?
Cann Group Limited has a beta of 0.087, indicating lower volatility than the overall market.